Banned / Annex II
apomorphine
Safety score · 0–100
Avoid
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
About
Apomorphine — a prescription dopamine-agonist drug for Parkinson disease. Banned from EU cosmetics under Annex II; pharmaceutical-only, not a skincare ingredient.
Skin benefits
- No cosmetic use; prescription Parkinson disease drug
Known concerns
- EU Cosmetics Regulation Annex II — banned
- Potent dopamine receptor agonist prescription drug
- Severe systemic effects: nausea, hypotension, hallucinations
- Should never appear in any cosmetic product
References
EU CosIng database
European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.
Related banned / annex iis
Check your shelf
Find apomorphine in your products.
Scan any cosmetic product with LuxSense to see if it contains apomorphine and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.